Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 44% ± 22% | |
peripheral blood | 16 studies | 30% ± 12% | |
lung | 14 studies | 26% ± 9% | |
eye | 10 studies | 48% ± 16% | |
kidney | 6 studies | 27% ± 9% | |
heart | 5 studies | 42% ± 13% | |
uterus | 4 studies | 20% ± 5% | |
liver | 4 studies | 34% ± 11% | |
intestine | 4 studies | 20% ± 3% | |
adipose | 4 studies | 37% ± 17% | |
placenta | 3 studies | 38% ± 11% | |
breast | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2680.72 | 1445 / 1445 | 100% | 13.24 | 183 / 183 |
prostate | 100% | 3709.77 | 245 / 245 | 100% | 12.65 | 502 / 502 |
thymus | 100% | 7972.39 | 653 / 653 | 100% | 11.18 | 603 / 605 |
ovary | 100% | 2091.41 | 180 / 180 | 99% | 10.09 | 427 / 430 |
kidney | 100% | 3383.04 | 89 / 89 | 98% | 7.81 | 886 / 901 |
brain | 100% | 7561.92 | 2629 / 2642 | 99% | 8.61 | 695 / 705 |
breast | 100% | 3323.15 | 457 / 459 | 98% | 7.21 | 1101 / 1118 |
lung | 100% | 4005.80 | 578 / 578 | 97% | 7.58 | 1121 / 1155 |
pancreas | 99% | 2940.42 | 326 / 328 | 97% | 6.01 | 173 / 178 |
adrenal gland | 100% | 4732.66 | 258 / 258 | 97% | 6.85 | 222 / 230 |
uterus | 100% | 3475.18 | 170 / 170 | 96% | 6.24 | 442 / 459 |
skin | 100% | 2742.46 | 1805 / 1809 | 96% | 5.97 | 454 / 472 |
stomach | 100% | 3803.69 | 359 / 359 | 95% | 6.85 | 271 / 286 |
bladder | 100% | 3017.29 | 21 / 21 | 93% | 6.52 | 469 / 504 |
intestine | 100% | 2872.92 | 966 / 966 | 86% | 4.85 | 453 / 527 |
liver | 76% | 950.26 | 172 / 226 | 61% | 2.72 | 249 / 406 |
adipose | 100% | 3620.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 3549.03 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.89 | 1 / 1 |
blood vessel | 100% | 2989.53 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 2971.61 | 796 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 6.73 | 44 / 45 |
heart | 97% | 4287.62 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 2144.70 | 844 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 2.95 | 19 / 29 |
eye | 0% | 0 | 0 / 0 | 45% | 1.85 | 36 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0140238 | Biological process | presynaptic endocytosis |
GO_0032880 | Biological process | regulation of protein localization |
GO_0061024 | Biological process | membrane organization |
GO_2000369 | Biological process | regulation of clathrin-dependent endocytosis |
GO_0050821 | Biological process | protein stabilization |
GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
GO_0006468 | Biological process | protein phosphorylation |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0043195 | Cellular component | terminal bouton |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0031252 | Cellular component | cell leading edge |
GO_0005829 | Cellular component | cytosol |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0035612 | Molecular function | AP-2 adaptor complex binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005112 | Molecular function | Notch binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | AAK1 |
Protein name | AAK1 protein AP2 associated kinase 1 Alternative protein AAK1 AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1) |
Synonyms | KIAA1048 |
Description | FUNCTION: Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis . Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1 . Preferentially, may phosphorylate substrates on threonine residues . Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes . Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes . Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity . .; FUNCTION: (Microbial infection) By regulating clathrin-mediated endocytosis, AAK1 plays a role in the entry of hepatitis C virus as well as for the lifecycle of other viruses such as Ebola and Dengue. . |
Accessions | E9PG46 A0A096LNZ0 ENST00000409068.5 ENST00000623317.3 B7ZLC4 ENST00000406297.7 [Q2M2I8-2] ENST00000606389.8 A0A096LP60 ENST00000624900.1 Q2M2I8 Q9BUD9 L0R804 ENST00000409085.9 [Q2M2I8-1] A0A096LP25 |